There is a word that rarely comes up in conversations about transthyretin cardiac amyloidosis (ATTR-CM): progression.
We talk about diagnosis. We talk about awareness. We talk about new medications and breakthroughs, about hope and slowing things down. Those conversations matter deeply. They save lives. They extend time. But progression — the quiet, steady unfolding of what this disease takes — often stays unspoken. Almost avoided. As if naming it might somehow make it happen faster.
Yes, we have medication now. That matters. It is a gift many did not have before. Treatment can slow the disease, sometimes significantly. But slow does not mean stop.
Progression doesn’t announce itself all at once. It doesn’t arrive with a single moment you can circle on a calendar. It doesn’t follow a straight line or a predictable timeline. What happens in one body doesn’t always happen in another. That uncertainty alone can feel heavy — sometimes heavier than any single symptom. Progression is often subtle. Quiet enough to dismiss at first.
A button that takes a little longer to fasten. Fingers that don’t quite cooperate the way they did last year. A shirt that once felt effortless to put on becomes something you concentrate on. You adapt. You adjust. You don’t complain. You tell yourself it’s fine.
And then one day, without a clear moment to point to, that ability is gone.
Progression looks like legs you trusted without question — legs you assumed would carry you wherever you needed to go — beginning to feel unreliable. They tire faster. They feel heavier. Stairs feel steeper. The distance between where you are and where you want to be grows longer, even if the space itself hasn’t changed. Days turn into months. Months into years. The weakening is gradual enough that others may not notice, but constant enough that you do. This is the part of ATTR that is hardest to explain, and maybe hardest to witness. Especially for those who love us.
From the outside, slowing progression can look like stability. It can look like success. From the inside, it can still feel like loss. Even when medicine is doing exactly what it is meant to do, things can still slip away. Not all at once. Not dramatically. But persistently. Progression reshapes how you think about time. It introduces a kind of grief that doesn’t arrive all at once, but in increments. You grieve abilities while you still have them. You grieve independence while still appearing capable. You learn to hold gratitude and mourning in the same breath, often without the words to explain that both are true at the same time. And yet, silence around progression doesn’t make it easier. It makes it lonelier.
We need space to say that slowing the disease is not the same as stopping the losses. That hope and realism can exist together. That acknowledging progression is not giving up — it is telling the truth about life with ATTR.
There is courage in naming what is happening. There is dignity in honoring what the body has carried us through, even as it changes. Progression is a hard word. But avoiding it does not protect us.
What might is talking about it — honestly, gently. Because those living with ATTR are not just surviving a diagnosis. We are navigating a slow, unpredictable unfolding.
Sign up here to get the latest news, perspectives, and information about ATTR-CM sent directly to your inbox. Registration is free and only takes a minute.
